A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies

NCT06388902 · clinicaltrials.gov ↗
PHASE1
Phase
SUSPENDED
Status
120
Enrollment
INDUSTRY
Sponsor class

Stopped Due to drug stability and global interests, it is currently in a suspended state.

Conditions

Interventions

Sponsor

BioRay Pharmaceutical Co., Ltd.